The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhananjay Barot
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dhananjay Ashokkumar Barot, a member of the promoter group of Senores Pharmaceuticals, sold 5,100 equity shares in the open market on August 18, 2025. His stake fell marginally from 0.72% (330,000 shares) to 0.71% (324,900 shares), a reduction of just 0.01%. The disclosure was filed under Regulation 29(2) of SEBI's SAST Regulations with both BSE and NSE. The total share capital of the company remains unchanged at 46,053,588 equity shares.
This is a very small, routine sale by a promoter with negligible impact on overall promoter holding or company shareholding pattern. Investors are unlikely to see any meaningful effect on the stock price or control structure from this transaction.